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Pemberton et al., page 457
HapMap has grown. With the third release, The Interna-
tional HapMap Consortium has analyzed more samples
from the original four populations, and they’ve also
studied samples from seven additional populations. The
study design involved collecting samples from known
related individuals for some of the population groups,
but with such a large number of participants, there are
also likely to be unknown relative pairs included as well.
Because the performance of certain analyses on the
HapMap 3 samples might be confounded by unidentified
relationships, recognition of all closely related individuals
is important. In this issue, Pemberton and colleagues use
the genome-wide SNP data of the population samples to
look for unknown pairs of close relatives. The authors stick
to predicting relationships closer than first cousins,
because assignment of more distant relationships can be
less reliable. Following their analysis, they report that the
sex of some of the samples is likely to have been misla-
beled, a few of the relationships reported by HapMap are
incorrect, and two of the samples are either monozygotic
twins or duplicates. They then delineate all the unknown
relationships that they infer from the data. In the end,
Pemberton and colleagues present two lists that will aid
researchers using these HapMap 3 samples: one list is of
the samples that should be removed if a data set of individ-
uals without any parent-offspring or full-sibling pairs is
needed, and the second list is of the samples to exclude if
half sibling, grandparent-grandchild, and avuncular pairs
are to be removed as well.Move Over, GT, There’s a New Splice Site in Town
Hartmann et al., page 480
Fanconi anemia (FA) is a genetic disorder of blood cells that
leads to bone marrow failure. Rather than producing
enough new blood cells to maintain the body, the bone
marrow of FA patients often produces abnormal blood
cells, which results in the development of leukemia. This
serious condition is caused by mutations in at least 13
genes involved in DNA repair. FA can be classified into
three distinct categories, which differ in severity and
genetic cause. FA type C (FANCC) is caused by mutations
in FANCC and belongs to the category with the least severe1Science Editor, AJHG; 2Deputy Editor, AJHG
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gate the disease mechanism of patients with FANCC. They
identify the same c.456þ4A>T mutation in nine FANCC
patients from thee different pedigrees. The mutation
changes a 50 (donor) splice site from ‘‘GT’’ to ‘‘TT’’ at the
DNA level. Although around 99% of all 50 splice sites use
the ‘‘GT’’ consensus sequence, ‘‘AT’’ can also serve as
a splice donor site. ‘‘TT’’ has not been considered a donor
splice site sequence at all. Thus, the c.456þ4A>Tmutation
has been predicted to prevent correct splicing in FA
patients. However, Hartmann and colleagues find the
‘‘TT’’ sequence to act as a 50 splice donor site some of the
time, resulting in a small amount of correctly spliced
FANCC. This correctly spliced product results in low levels
of normal posttranscriptionally processed protein,
accounting for the milder phenotype of these patients. In
addition to providing a mechanism for the phenotypic
difference in FANCC patients, this work suggests that
gene therapy for splice-site mutations may be able to
correct mRNA processing in FA and other diseases.Searching for CNV Hotspots
Fu et al., page 494
In the last few years, there has been a growing recognition
of the contribution of copy-number variants (CNVs) to the
risk of developing both Mendelian and complex diseases.
Previous work has examined the mutation rate of some
CNV loci, and results suggest that these sites mutate
more frequently than do single-nucleotide sites and that
there is a great deal of variation in the mutation rates of
CNV loci. Therefore, investigating CNVs involves not
only looking for an association with disease but also deter-
mining why CNVs form in the genome where they do and
why some unstable regions are affected more frequently
than others. In this issue, Fu and colleagues endeavor to
estimate the mutation rate of CNV loci throughout the
genome and establish whether CNV hotspots exist. The
first step in their study is to develop methodology that
they call CNVMut, which allows them to predict CNV
mutation rates by using SNP data. The authors then apply
CNVMut to data from CNV loci in the YRI, CEU, and
JPTþCHB HapMap populations. Along with observing
diversity in the values of mutation rates at these loci,
they also identify sites that are predicted to be potential
CNV mutational hotspots. The genomic architecture ofGenetics. All rights reserved.
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these CNV hotspots is compared to that of regions with
lower mutation rates in an effort to figure out which
features might contribute to their increased instability. As
the importance of CNVs in disease increases, so too does
the need to understand the mechanisms behind the crea-
tion of CNVs.A Genetic Contribution to Male Infertility
Bashamboo et al., page 505
Infertility can be a huge obstacle for couples trying to
have children, and even with improvements in assisted
reproductive techniques, many couples struggle to
conceive. Previous work supports genetic factors as
a contribution to a percentage of cases of male infertility:
chromosomal abnormalities are responsible for some
cases, and mutations in single genes have been found in
others. One gene in particular, NR5A1, encodes a protein
known to be involved in gonadal development, and
mutations can cause complex phenotypes that include
infertility. Here, Bashamboo report their findings that
NR5A1 mutations can also cause infertility in men who
are otherwise healthy. The men carrying these mutations
are all affected with at least moderate oligozoospermia,
and all six mutations fall within the same region of the
protein. The authors perform functional studies on muta-
tions that were heterozygous in the seven infertile men.
They find that, although the mutant proteins share a local-
ization pattern with that of the wild-type protein, their
ability to activate transcription of target genes is signifi-
cantly disrupted. On the basis of these data, NR5A1 could448 The American Journal of Human Genetics 87, 447–448, Octoberbe added to the list of genes that, when mutated, cause
male infertility.Sphingolipids and Neurodegeneration
Rotthier et al., page 513
Sphingolipids are proteins found within the plasma
membrane and are thought to play a protective role against
harmful environmental factors. They have also been
shown to be involved in cell signaling pathways important
for apoptosis, proliferation, and stress responses. Sphingo-
lipids are particularly important in nervous tissue, because
mutations in many of the genes involved in sphingolipid
biosynthesis result in neurodegenerative diseases. Heredi-
tary sensory and autonomic neuropathy type I (HSAN-I)
is one such disorder. HSAN-I is the most common type of
HSAN and is transmitted in an autosomal-dominant
manner. HSAN-I is characterized by a lack of feeling in
the lower limbs, chronic ulcerations of the feet, and
progressive destruction of affected bones. About 19% of
HSAN-I patients are known to have mutations in SPTLC1,
encoding the first subunit of serine palmitoyltransferase
(SPT). SPTLC1 dimerizes with either SPTLC2 or SPTLC3
to form an active enzyme that catalyzes the first (and
rate-limiting) step of sphingolipid biosynthesis. Here,
Rotthier and colleagues sequence SPTLC2 and SPTLC3 in
a cohort of HSAN patients who do not harbor SPTLC1
mutations. They identify three different missense muta-
tions in SPTLC2 in four index patients. Their functional
work supports the pathogenicity of these mutations and
highlights SPTLC2 mutations as causative for HSAN-I.8, 2010
